Ripudamanjit Singh

Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis

Thomas A. White, Tucker F. Johnson, Natalia Zarzhevsky et al. · Blood · 2010 · 54 citations · Full text

Medicine, Hematology, Pathobiology +14

High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19

Laura De Michieli, Olatunde Ola, Jonathan D Knott et al. · Clinical Chemistry · 2021 · 53 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Role for Tissue Factor Pathway in Murine Model of Vascular Remodeling

Ripudamanjit Singh, Shuchong Pan, Cheryl S. Mueske et al. · Circulation Research · 2001 · 48 citations · Full text

Medicine, Biochemistry, Pharmacology +14

Frequency, Etiology, Treatment, and Outcomes of Drug-Eluting Stent Thrombosis During One Year of Follow-Up

Gurpreet S. Sandhu, Brendan Doyle, Ripudamanjit Singh et al. · The American Journal of Cardiology · 2006 · 25 citations

Medicine, Cardiology, Pharmacotherapy +12

Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling

Ripudamanjit Singh, Shuchong Pan, Cheryl S. Mueske et al. · Thrombosis and Haemostasis · 2003 · 24 citations

Medicine, Pathobiology, Cardiovascular Genetics +14